Merck & Co Inc
NYSE:MRK
Merck & Co Inc
NYSE:MRK
Price:
128.26 USD
-0.42%
Market Closed
Updated:
May 3, 2024
Merck & Co Inc
Cash from Investing Activities
|
Merck & Co Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
ZTS
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Cash from Investing Activities
-$777m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-16%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Merck & Co Inc's Cash from Investing Activities?
Cash from Investing Activities
-14.1B
USD
-14.1B
USD
Based on the financial report for Mar 31, 2024, Merck & Co Inc's Cash from Investing Activities amounts to -14.1B USD.
What is Merck & Co Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-9%
-9%
Over the last year, the Cash from Investing Activities growth was -129%. The average annual Cash from Investing Activities growth rates for Merck & Co Inc have been -18% over the past three years , and -9% over the past ten years .
You don't have any saved screeners yet
